Banco Santander (Brasil) S.A. (SANB11)
Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026
Key indicators
| Last close | BRL 28.37 |
|---|---|
| 52-week range | 24.92 – 36.45 |
| Return, 1 month / 3 months | −4.7% / +8.6% |
| Return, 1 year / 3 years | +10.6% / +32.9% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 31.3% |
| Worst drawdown (1 year) | -30.6% |
| Average daily value traded | 157.71M BRL |
| Dividend yield | 8.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco Santander (Brasil) S.A. is a Brazilian bank that serves individuals and companies through a network of branches and digital channels. It offers current and savings accounts, personal and payroll loans, credit cards, mortgages and insurance to retail customers, while businesses use its commercial banking, cash management, trade finance and investment services. The bank is based in Sao Paulo and operates across Brazil, with its units traded on the local exchange.
The shares are listed on the Sao Paulo Exchange in Brazil under the code SANB11, and the price on this page is in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco Santander (Brasil) S.A. (SANB11) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 28.37 on 16 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 376 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.6% and over the last three months it rose 8.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.6% | ||
| From 52-week high | -21.5% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.6% | ||
| 6-month return | -6.4% | ||
| 12-month return, skipping the last month | 16.1% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.6% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 157.71M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 75 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.1% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | −2.4% |
|---|---|
| 1 month | −4.7% |
| 3 months | +8.6% |
| 6 months | −6.4% |
| 1 year | +10.6% |
| 3 years | +32.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 29.49 / 29.43 |
|---|---|
| Golden / death cross (60 days) | Golden, 4 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.73 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Jul 2026 | BRL 0.5347 |
| 20 Apr 2026 | BRL 0.5347 |
| 20 Jan 2026 | BRL 0.5359 |
| 2 Jan 2026 | BRL 0.1661 |
| 21 Oct 2025 | BRL 0.5359 |
| 17 Jul 2025 | BRL 0.5359 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.